Enjoy complimentary customisation on priority with our Enterprise License!
The transfection technologies Market is projected to grow by USD 526.14 million with a CAGR of 9.05%, during the forecast period 2021 to 2026.
This transfection technologies market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers transfection technologies market segmentation by end-user (pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes) and geography (North America, Asia, Europe, and the Rest of the World (ROW)). The transfection technologies market report also offers information on several market vendors, including Altogen Biosystems, Bio Rad Laboratories Inc., Biontex Laboratories GmbH, Boca Scientific Inc., F. Hoffmann La Roche Ltd., GENLANTIS, Inovio Pharmaceuticals Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, POLYPLUS TRANSFECTION S.A, Promega Corp., PromoCell GmbH, QIAGEN NV, SignaGen Laboratories, Takara Holdings Inc, and Thermo Fisher Scientific Inc. among others.
Download Report Sample to Unlock the Transfection Technologies Market Size for the Forecast Period and Other Important Statistics
The availability of innovative products is notably driving the transfection technologies market growth, although factors such as the lack of promotional activities may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the transfection technologies industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Transfection Technologies Market Driver
One of the key factors driving the transfection technologies market growth is the availability of innovative products. Vendors in the market are offering products with improved features to create their mark in the market, retain existing consumers, and attract prospective consumers. For instance, Neon Transfection System from Thermo Fisher Scientific is offered as a second-generation transfection system using an electronic pipette tip as an electroporation chamber. Its electroporation chamber can be used as a pipette. Its circular shape offers a significant advantage over cuvette-based systems. Furthermore, the design of the chamber allows the equal distribution of current between the cells, thereby maintaining a stable pH throughout the chamber, which increases cell viability. Such product offerings aid in attracting prospective consumers, leading to both increased sales and high volume production among vendors, which will propel the growth of the global transfection technologies market during the forecast period.
Key Transfection Technologies Market Trend
Increased use of dual-reporter assays and co-transfection experiments are a major trend influencing the transfection technologies market's growth. With the rise in biological and pharmaceutical research, there has been a rise in the use of dual-reporter systems due to their advantages over single reporter systems. A dual-reporter system allows expression to be normalized for cell number and transfection efficiency. With the use of a dual-reporter system, it is easy to determine if the effects are due to the treatment of the cells or a response from the experimental reporter. For instance, the Dual-Glo Luciferase Assay System from Promega allows the determination of the luminescent signal from two reporter genes in the same sample. The effective results offered and the fact that they can cut down on the costs of consumables will popularize the use of dual-reporter assays in the market. This advantage will lead to a rise in the adoption of dual-reporter assays and co-transfection experiments, leading to market growth.
Key Transfection Technologies Market Challenge
Lack of promotional activities is one of the key challenges hindering the transfection technologies market. The nature of the products makes it difficult for vendors to promote them. By establishing a marketing plan, vendors can ensure the success and sustainability of their businesses. For instance, social media can be used to promote content, establish online communities, and support lead generation activities. Vendors such as Promega have published online videos on YouTube to attract potential end-users. Other vendors need to follow suit to garner larger market shares and ensure improved product viability. Publishing a series of blogs and newsletters would help guide quality traffic to the company's website. This would allow vendors to sustain long-term marketing campaigns and encourage visitors to return. However, inadequate promotional activities will negatively impact market growth during the forecast period and prevent vendors from establishing a sizeable customer base.
This transfection technologies market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global transfection technologies market as a part of the global life sciences tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the transfection technologies market during the forecast period.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
This statistical study of the transfection technologies market encompasses successful business strategies deployed by the key vendors. The transfection technologies market is fragmented, and the vendors are adopting growth strategies such as organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.
The transfection technologies market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies
Our In-house experts produce extensive information on the value chain and parent market of the transfection technologies market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profits and also the optimization and evaluation of business strategies The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.
The report has further elucidated other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
For more insights on the market share of various regions Request PDF Sample now!
42% of the market’s growth will originate from North America during the forecast period. The US is the key market for transfection technologies market in North America. Market growth in this region will be slower than the growth of the market in Asia.
Increasing investments in new manufacturing facilities equipped with bioprocessing units and other equipment required for processes such as cell line development and cell culture will facilitate the transfection technologies market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID-19 Impact and Recovery Analysis
The outbreak of COVID-19 in 2020 affected all countries in North America, especially the US. The outbreak had a slight negative impact on clinical trials and donors for regenerative medicines in the region. A rise in the number of COVID-19 cases in the first quarter of 2020 led to the imposition of partial lockdowns in several countries, including Canada and Mexico. Thus, various non-urgent pharmaceutical operations, such as analytical testing, which could be halted or postponed, were either conducted in a limited capacity or halted as per the set guidelines. However, transfection technologies have been found to have potential uses in the treatment of COVID-19, as they aim at repairing, regenerating, and restoring the missing functions of organ cells. Thus, studying the interactions between the SARS-CoV-2 virus and host cells can be beneficial. Moreover, the lifting of lockdowns, the resumption of clinical trials, and the implementation of vaccination drives will lead to demand for transfection technologies in North America. Therefore, the regional market will likely register growth during the forecast period.
To gain further insights on the market contribution of various segments Request a PDF Sample
The transfection technologies market share growth in the pharmaceutical and biotechnology companies segment will be significant during the forecast period. With the growing prevalence of chronic diseases worldwide, there is a growing need for pharmaceutical and biotechnology companies to manufacture high-quality and regulatory-compliant drugs and therapeutics.
Besides the above-mentioned factors, the post-COVID-19 impact has brought forth a slowdown in or fast-tracked the demand for services or products. This report provides an accurate prediction of the contribution of all the segments to the growth of the transfection technologies market size and actionable market insights on the post-COVID-19 impact on each segment.
|
Transfection Technologies Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 9.05% |
|
Market growth 2022-2026 |
$526.14 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
8.02 |
|
Regional analysis |
North America, Asia, Europe, and the Rest of the World (ROW) |
|
Performing market contribution |
North America at 42% |
|
Key consumer countries |
US, Canada, Germany, China, Japan, and India |
|
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
|
Key companies profiled |
Altogen Biosystems, Bio Rad Laboratories Inc., Biontex Laboratories GmbH, Boca Scientific Inc., F. Hoffmann La Roche Ltd., GENLANTIS, Inovio Pharmaceuticals Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, POLYPLUS TRANSFECTION S.A, Promega Corp., PromoCell GmbH, QIAGEN NV, SignaGen Laboratories, Takara Holdings Inc, and Thermo Fisher Scientific Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by End-user
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
